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Summary
We have identified autoantibodies from two patients with primary biliary cirrhosis (PBC) that
recognize the nuclear envelope ofmammalian cells on indirect immunofluorescence microscopy.
These antibodies bind to a 58-kD integral membrane protein (p58) of the turkey erythrocyte
nuclear envelope, which has been previously identified as a membrane receptor for laminB (Worman,
H. J., J. Yuan, G. Blobel, and S. D. Georgatos. 1988. Proc. Nad. Acad. Sci. USA. 85 :8531). The
antibodies also bind to a 61-kD integral membrane protein (p61) of the rat liver nuclear envelope.
Affinity-purified antibodies eluted from turkey p58 bind to rat p61, showing that the two proteins
share an epitope(s) and that p61 is likely the rat liver lamin B receptor. In human nuclear envelopes,
the antigen recognized has an apparent molecular mass close to that of avian protein. These
findings, along with the previous discovery of autoantibodies against an integral membrane
glycoprotein (gp210) of the nuclear pore membrane in patients with PBC, suggest that antibodies
against integral membrane proteins of the nuclear envelope are characteristic ofa subset ofpatients
with PBC.
T
he nuclear membranes consist of three domains that are
morphologically distinct from each other (for reviews
see references 1 and 2). The outer nuclear membrane domain
contains attached ribosomes and, at many points, is continuous
with the rough endoplasmic reticulum (RER).' The nuclear
pore membrane domain, which connects the outer and inner
nuclear membranes and forms transcisternal circular pores,
contains attached pore complexes. The inner nuclear mem-
branedomain is attached to the nuclear lamina (3, 4), a struc-
ture composed of intermediate filament-type proteins, the
acidic B-type lamins and the neutral A-type lamins (5-8).
Although integral membrane proteins synthesized in the RER
can reach the inner nuclear membrane (9), presumably by
lateral diffusion via the pore membranes, it appears that inte-
gral membrane proteins are not randomly distributed between
each of the three envelope domains. Instead each domain ap-
pears to contain specific integral membrane proteins. The pore
membrane contains a recently characterized integral mem-
brane glycoprotein gp210, that presumably functions in the
attachment of the nuclear pore complex (10, 11) . The inner
I Abbreviations used in this paper: PBC, primary biliary cirrhosis; RER,
rough endoplasmic reticulum.
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membrane contains a number of unique proteins (12-14),
among them a receptor for lamin B (14).
A number of human autoimmune diseases have been as-
sociated with high titers of autoantibodies against the nu-
clear envelope. These antibodies yield characteristic nuclear
rim staining on immunofluorescence microscopy. Some of
the antigens with which these autoantibodies react have been
identified. For example, antibodies against A-type and B-type
lamins have been described in systemic lupus erythematosus
(15-17), autoimmune hepatitis (17, 18), and scleroderma (19).
Autoantibodies against gp210, an integral membrane glyco-
protein of the pore membrane domain, have been reported
in patients with primary biliary cirrhosis (PBC) (20-22). Here
we report, also in patients with PBC, autoantibodies against
the lamin B receptor, an integral membrane protein of the
inner nuclear membrane.
Materials and Methods
Indirect Immunofluorescence Microscopy.
￿
Detailed methods for im-
munofluorescence have been previously published (16) . HeLa cells
grown on cover slips were permeabilized for 6 min in methanol
at -20°C. Antibodies from patient 1 (see below) were used at
a 1:500 dilution. Second antibodies were affinity-purified goat
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Burlingame, CA) used at a 1:100 dilution .
Preparation ofNuclei and Nuclear EnvelopeFractions.
￿
Nuclei, nu-
clear envelope, and nuclear envelope subfractions were prepared from
rat liver as previously described (22) . Nuclear envelopes from turkey
erythrocytes were prepared according to GeorgatosandBlobel (23) .
Nuclei from HeLa cells were prepared as described earlier (20) and
nuclear envelopeswere prepared from these nuclei as described for
rat liver nuclei except that the DNase I/RNase A digestion step
at 4°C was for 3 h instead of 1 h and the last centrifugation step
was performed without a sucrose cushion .
Immunoblotting .
￿
SDS-solubilized proteins were subjected to elec-
trophoresis under reducing conditions on polyacrylamide gels ac-
cording to Laemmli (24) . Proteins were transferred to nitrocellu-
lose sheets by electrophoresis using a semi-dry method (25). All
the following stepswere carried out in 10mM Tris-HC1(pH7.4),
0.15 M NaCl, 0.1% Tween-20, and 50 g/liter non-fat milk (Car-
nation, Los Angeles, CA). Nitrocellulose strips were blocked for
1 h, incubated for 2 hwith the indicated dilution ofserum, washed
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Figure 1.
￿
Indirect immuno-
fluorescence microscopy of HeLa
cells with the autoimmune anti-
bodies. (a) Immunofluorescence
micrograph using a 1:500 dilution
of serum of patient 1 (see Mate-
rials and Methods); (b) staining of
DNA of same cells with the
fluorescent dye Hoechst 33258 .
Shown are two interphase cells
(open arrowheads), one cell in
metaphase (closed arrowhead) and
two cells in telophase (arrows) . Bar,
10 mm .
four times, incubated with a 1:2,000 dilution of 121I-protein A
(New England Nuclear, Wilmington, DE), washed four more times,
andthen exposed to x-ray film at -70°Cwith intensifying screens .
Affinity Purification ofAntibodies.
￿
Turkey erythrocyte nuclear
envelopes were extractedwith urea as described (23) andimmuno-
blotted with the patient's serum diluted 1:100 . The band corre-
sponding to the58-kDLmin Breceptor was excised and antibodies
eluted according to Smith and Fisher (26) . A band of the same
blot in the 150-kD region was eluted under the same conditions
and the eluate used as control .
Antibodies.
￿
Autoimmune antibodies were detected by indirect
immunofluorescence microscopy on air-dried rat liver tissue sec-
tions. Both sera gave continuous perinuclear staining up to a dilu-
tion of 1:500 . Monospecific rabbit IgG specific forhuman Ig heavy
and light chains (Dako, Kobenhaven, Denmark) indicated that the
antibodies were polyclonal IgG and IgM molecules .
Guinea pig polyclonal antibodies against turkey p58 have been
previously described (14) . The followinghuman autoimmune sera
were used as controls : two sera directed against gp210, four an-Figure 2 .
￿
Fractionation behavior of the 61AD antigen upon extraction of rat liver nuclear envelopes with Triton X-100/N2CI or alkaline solu-
cions. Nuclear envelopes were incubated with either 2% Triton X-100/0.3M NaCl, 0.1 M NaOH, or Na2CO3 (pH 11.5) (as indicated in the
figure) and centrifuged to yield supernatant (S) and pellet (P) fractions . Polypeptides in these fractions or of unfractionated nuclear envelopes
(NE), were separated by SDS-PAGE and visualized by Coomassie blue staining (lanes 1-8) or were transferred to nitrocellulose (lanes 9-15) and
probed with a 1:200 dilution of the serum of patient 1 . Lane 1 contains molecular mass markers . Arrows in left panel refer to lamins A (74
kD), B (68 kD), andC (60 kD) .
tisera directed against lamins, and two sera without antinuclear
antibodies . All of these sera were previously characterized (17, 20,
22) .
Patients.
￿
Sera were obtained from two patients . Patient 1 was
a 36-yr-old woman with PBC diagnosedby liver biopsy. She had
no associated rheumatic symptoms and no antimitochondrial anti-
bodies . Patient 2wasa 59-yr-old woman withPBC and associated
Sjogren's syndrome . The diagnosiswas determined by liver biopsy.
She did not have antimitochondrial antibodies but her serum did
contain antibodies against histones .
Results
Autoantibodies Stain the Nuclear Envelope .
￿
Indirect im-
munofiuorescence microscopy ofHeLa cells fixed at different
stages of the cell cycle with the serum of patient 1 yielded
a staining pattern that is characteristic for components ofthe
nuclear envelope (27, 28) . Interphase cells showed staining
of the nucleus enhanced at the nuclear rim (Fig . 1 a, open
arrowheads) . Metaphase cells containing disassembled com-
ponents of the nuclear envelope throughout the cytoplasm
showed a diffuse staining of the entire cell (Fig. 1 a, closed
arrowheads) . Telophase cells with the nuclear envelope mostly
reassembled showed again intense staining largely coincident
with the condensed daughter chromosomes (Fig. 1 a, arrows).
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The Autoantigen Is an Integral Membrane Protein .
￿
To de-
termine the molecular mass of the reactive autoantigen(s),
we isolated rat liver nuclear envelopes and separated their pro-
teins bySDS-PAGE. The separated proteins were stained with
Coomassie blue (Fig. 2, lanes 2), or transferred to nitrocellu-
lose sheets and probed with the serum of patient 1 . A poly-
peptide with an apparent molecular mass o£ 61 kD was found
to react with the autoantibodies (Fig. 2, lane 9) .
To determine whether the 61-kD polypeptide is a periph-
eral or integral membrane protein, rat liver nuclear envelopes
were extracted with either 0.1 M NaOH, or0.1 M N2C03
at pH 11.5 or were solubilized by a solution of2% Triton
X-100/0.3M NaCl . The 61-kD polypeptide was resistant to
alkaline extraction (Fig . 2, lanes 12-15) and therefore frac-
tionates as an integral membrane protein . As expected for
an integral membrane protein, it was solubilized by a solu-
tion of detergent and high salt (Fig. 2, lanes 10 and 11) .
The Autoantigen Is the Previously Identified Lamin B Recep.
tor . Several integral membrane proteins of molecular masses
similar to the 61-kD antigen have recently been identified
in the inner nuclear membrane (13, 14) . Among these is the
lamin B receptor of nuclear envelopes from avian erythro-
cytes with an apparentM r of 58 kD (14) . Using guinea pig
antibodies against the avian lamin B receptor (p58) (14), weFigure 3 .
￿
The 61-kD rat and the 59-kD human antigen are homologues of the 58-kD lamin B receptor of turkey. Polypeptides in total rat
liver nuclear envelopes (RLNE) and supernatants (S) and pellets (P) of urea incubated turkey erythrocyte nuclear envelopes (TENE) were sepa-
rated by SDS-PAGE and either visualized by Coomassie blue staining (A, lanes 2-4), or transferred to nitrocellulose (B, lanes 5-7 and 8-10) and
probed with either the guinea pig antiserum (1:500 dilution) against the turkey lamin B receptor (a-p58) (lanes 5-7) or with serum of patient 1
diluted 1:200 (ANA) (lanes 8-10) . In C, polypeptides of rat liver nuclear envelopes (RL) and pellets from urea extracted turkey erythrocytes nu-
clear envelopes (TE) were subjected to SDS-PAGE, transferred to nitrocellulose, and probed with affinity-purified antibodies of the antiserum of
patient 1, using turkey p58 as a ligand (lanes 11, 12) . Lanes 13 and 14 correspond to control antibodies (see Materials and Methods) . Immuno-
blots of SDS-PAGE resolved polypeptides of HeLa cell nuclear envelopes (HE) and of crude HeLa nuclei (HN) revealed with serum of patient 1
are shown in lanes 15 and 16, respectively. The numbers 61 and 58 on the right of lane 16 indicateM in kD of lamin B receptor in different
species .
compared the reactivity of these antibodies with that of the
human autoantibodies using blots of SDS-PAGE separated
polypeptides of avian (turkey erythrocytes) and mammalian
(rat liver) nuclear envelopes (Fig . 3) . As reported previously,
the guinea pig antibodies reacted with p58 of avian erythro-
cyte nuclear envelopes most of which was not extracted by
8 M urea (Fig. 3, compare lanes 6 and 7) . The same serum
did not react with any polypeptide of rat liver nuclear enve-
lopes (Fig . 3, lane 5) . The serum of patient 1 reacted also
with a 58-kD polypeptide ofthe avian nuclear envelopes that
was not extracted by 8M urea (Fig. 3, compare lanes 9 and
10) . Thus, by the criteria ofM, as well as resistance to ex-
traction by 8M urea, the human serum and the guinea pig
anti-p58 antiserum recognized an identical polypeptide in the
nuclear envelope of avian erythrocytes, indicating that this
polypeptide contains epitope(s) that are recognized by both
sera and, moreover, that the serum of patient 1 is directed
against the lamin B receptor .
As the serum of patient 1 reacted with a single polypep-
tide of 61 kD of rat liver nuclear envelopes (Fig . 3, lane 8)
that, like p58 of turkey erythrocyte nuclear envelopes, is an
integral membrane protein, it is likely that turkey p58 and
rat p61 are homologous . To further substantiate this conclu-
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sion, we affinity purified the patient's serum using turkey
p58 as a ligand and tested the affinity-purified antibodies on
blots containing SDS-PAGE separated rat liver (Fig. 3, lane
11) or turkey erythrocyte (Fig . 3, lane 12) nuclear envelope
proteins. The affinity-purified antibodies reacted with a 61-
kD polypeptide in rat liver nuclear envelopes (lane 11) and
a 58-kD polypeptide in turkey erythrocyte nuclear envelopes
(lane 12) . As a control, material that was eluted from pro-
teins other than p58 of turkey erythrocyte nuclear envelopes
(see Materials and Methods) did not react with any proteins
of either rat liver (lane 13) or turkey erythrocyte (lane 14)
nuclear envelopes.
We also tested the serum of patient 1 on nitrocellulose blots
ofSDS-PAGE separated polypeptides of a crude nuclear frac-
tion ofHeLa cells (Fig. 3, lane 16) or with a nuclear envelope
fraction derived from this nuclear fraction (Fig. 3, lane 15) .
Again a single polypeptide reacted, but in these cells the M,
of the reactive protein was -59 kD, less than the rat liver
61-kD protein but close to the turkey erythrocyte 58-kD
protein .
As the autoimmune serum of patient 2 gave the identical
immunofluorescence pattern (data not shown) as that observed
for the autoimmune serum of patient 1, we tested both an-Figure 4 .
￿
Immunoblot comparing the sera of patients 1 and 2 . Im-
munoblots were performed with SDS-PAGE resolved polypeptides of
either total rat liver (RL) nuclear envelopes (lanes 1 and 3) or urea-
extracted turkey erythrocyte (TE) nuclear envelopes (lanes 2 and 4) .
Serum from patient 1 (ANA 1) was used in lanes 1 and 2 and serum
from patient 2 (ANA 2) was used in lanes 3 and 4 . Molecular masses
of the two immunoreactive components are indicated at the left of
lane 1 .
tisera side by side on blots containing SDS-PAGE resolved
polypeptides ofrat liver and turkey erythrocyte nuclear enve-
lopes (Fig. 4) . As in the case of patient 1 (Fig. 4, lanes 1
and 2), the autoimmune serum ofpatient 2 reacted with only
a single protein of 61 kD in rat liver nuclear envelopes (Fig.
4, lane 3) or of 58 kD in turkey erythrocyte nuclear enve-
lopes (Fig. 4, lane 4) .
These sera were the only two of 66 directed against nu-
clear envelope proteins that recognized the rat liver 61-kD
integral membrane protein . 24 of the sera examined were
directed against nuclear lamins (17 and unpublished data) and
40 against gp210 (17, 20, 22, 29) . Besides the two character-
ized in this study, eight of these sera used as controls in im-
munoblotting experiments ofavian nuclear envelopes did not
recognize the lamin B receptor (p58).
Discussion
Antinuclear antibodies are found in a wide variety of au-
toimmune diseases. Several antigens responsible for homo-
geneous, speckled, or nucleolar labeling of the nuclei have
been identified (30) . Because of the lower frequency of au-
toantibodies that stain the nuclear periphery, only a few of the
antigens recognized by these antibodies have been identified .
Among these are the A-type and B-type lamins associated
with the inner nuclearmembrane domain of the nuclear enve-
lope . Antibodies against these proteins are found in patients
with different autoimmune diseases (15-19) . Recently, an in-
tegral membrane glycoprotein of the poremembrane domain
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of the nuclear envelope gp210 was identified as an antigen
that is recognized by sera ofsome patients with PBC (22) .
In the present study we have identified anew autoantigen of
the nuclear envelope in two patients withPBC . This antigen
is an integral protein of the inner nuclear membrane. On im-
munoblotting of rat liver nuclear envelopes, these antibodies
recognized an integral membrane protein of molecular mass
61 kD, suggesting that the target antigen could be the lamin
B receptor, a protein first identified in turkey erythrocyte nu-
clear envelopes with a similar molecular mass (14) . The close
similaritybetween these proteinswas confirmed by the finding
that the autoantibodies reacted with the avian laminB receptor
(p58) . Antibodies affinity purified against turkey p58 were
furthermore able to react with rat p61, demonstrating that
an interspecies conserved epitope ofthe lamin B receptor was
shared by the avian and rat proteins . The antibodies also reacted
with a protein of similar molecular mass (N59 kD) inhuman
nuclear envelopes, suggesting that cross-reactive proteins are
present in all three of the species examined .
PBC is a chronic liver disease ofunknown etiology. Histo-
logically, PBC is characterized by progressive inflammatory
destruction ofthe intrahepatic bile ducts with eventual progres-
sion to cirrhosis (31) . Diagnosis is based on immunological
and/or pathological criteria (31-33) . The presence of an-
timitochondrial autoantibodies directed against a family of
antigens termedM2 is characteristic ofPBC (34) . Several con-
stituents of theM2 antigens have been identified (35-38) and
the corresponding antibodies shown to be present in high
titer and with a high frequency (90--95%) in patients with
PBC . However, they are not specific for PBC and are some-
times present in other autoimmune diseases (39-41) . Of note,
the two patients characterized in this study did not have an-
timitochondrial antibodies.
Antinuclear antibodies are also found in patients withPBC .
Antibodies to histones, which were present in the serum of
patient 2 of this study, are present in 74% of patients with
PBC (42), but are also found in association with other au-
toimmune diseases (30) . Antibodies to gp210 (see above) are
found in only 27% of the patients with PBC, but they are
likely highly specific for this disease since they have not yet
been found associated with other diseases (29) . So far anti-
bodies to the laminB receptor also appear to be disease specific,
as they have not yet been detected in any published series
in which samples were screened from patients with other
autoimmune diseases or liver diseases . However, more anti-
bodies directed against the lamin B receptor:have to be ana-
lyzed to assess the prevalence and the specificity of this new
immunological marker. Thus, it appears that the two fami-
lies ofautoantibodies directed against integral membrane pro-
teins of the nuclear envelope are found exclusively in PBC .
In contrast, autoantibodies against the nuclear lamins, which
are peripheral proteins of the nuclear envelope, have been
mainly reported in patients with lupus-like syndromes and
autoimmune hepatitis (15-18) . Why antibodies to integral
membrane proteins of the nuclear envelope are restricted to
patients with PBC is not known .
Epitope(s) recognized by immunoglobulins in a few au-
toimmune diseases includingPBC have recently been identified(43-45). As the cloning and sequencing of the cDNA for
p58has been recently completed (46), this identification will
now be possible for this protein. This is of importance since
autoantibodies in this study are directed against conserved
domain(s) of the lamin B receptor which may be of func-
tional significance. Data suggest that autoantibodies to the
lamin B receptor reported here areantiidiotypic to some lamin
B autoantibodies (Lassoued, K., F. Danon, andJ.C. Brouet,
manuscript submitted for publication). Thus the conserved
epitope(s) that is the target of these anti-bodies could be the
binding site of the lamin B receptor to lamin B.
Therole of autoantibodies in the etiology and pathogen-
esis of autoimmune diseases is not clear. For example, the
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